CNTA
Centessa Pharmaceuticals
CNTA
CNTA
69 hedge funds and large institutions have $841M invested in Centessa Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
46% more capital invested
Capital invested by funds: $577M → $841M (+$264M)
19% more funds holding
Funds holding: 58 → 69 (+11)
1.95% more ownership
Funds ownership: 74.25% → 76.2% (+1.9%)
Holders
69
Holding in Top 10
5
Calls
$216K
Puts
$77K
Top Buyers
| 1 | +$34.8M | |
| 2 | +$33.9M | |
| 3 | +$14.1M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.21M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.73M |
Top Sellers
| 1 | -$69.8M | |
| 2 | -$7.3M | |
| 3 | -$3.52M | |
| 4 |
Morgan Stanley
New York
|
-$3.29M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.12M |